Zobrazeno 1 - 10
of 89
pro vyhledávání: '"S J, Hollenbach"'
Publikováno v:
Journal of Thrombosis and Haemostasis. 15:1747-1756
Essentials There is currently no approved reversal agent for factor Xa (FXa) inhibitors Andexanet alfa has been developed to reverse the anticoagulant effects of FXa inhibitors Andexanet reduced blood loss and anticoagulation markers in rivaroxaban-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aac481bdbd3a392d937a2bd404b74121
https://doi.org/10.1111/jth.13768
https://doi.org/10.1111/jth.13768
Autor:
Chen, Hanxu1 (AUTHOR), Bian, Feika1 (AUTHOR), Luo, Zhiqiang1 (AUTHOR), Zhao, Yuanjin1,2,3 (AUTHOR) yjzhao@seu.edu.cn
Publikováno v:
Advanced Science. 6/12/2024, Vol. 11 Issue 22, p1-11. 11p.
Publikováno v:
Thrombosis and haemostasis. 77(6)
In order to investigate the respective roles of prothrombinase and intrinsic tenase (IXa/VIIIa) in venous thrombosis, we compared the anti-thrombotic efficacy of inhibitors of these two coagulation complexes. The agents tested were dansyl-Glu-Gly-Arg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5feba8e9ccc2ba245f1ae65367ed9428
https://pubmed.ncbi.nlm.nih.gov/9241747
https://pubmed.ncbi.nlm.nih.gov/9241747
Publikováno v:
The Journal of Trauma: Injury, Infection, and Critical Care. 26:176-182
We developed a fixed-volume porcine hemorrhage model that simulates the rapid exsanguination of combat or civilian trauma victims. In this study we compared the ability of colloid resuscitation solutions to prevent death after an otherwise lethal hem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140ca833f746836070c8c491388efa1b
https://doi.org/10.1097/00005373-198602000-00015
https://doi.org/10.1097/00005373-198602000-00015
Autor:
Kofinti, Raymond Elikplim1 (AUTHOR) rkofinti@ucc.edu.gh, Koomson, Isaac2,3 (AUTHOR), Peprah, James Atta4 (AUTHOR)
Publikováno v:
Journal of Economic Inequality. Mar2024, Vol. 22 Issue 1, p49-67. 19p.
Publikováno v:
Green Chemistry; 7/7/2024, Vol. 26 Issue 13, p7849-7856, 8p
Publikováno v:
Surgery, gynecologyobstetrics. 161(3)
Despite the array of hemorrhage models, animal species and experimental designs, it seems clear that naloxone with or without volume replacement has no place in the treatment of rapidly exsanguinating traumatized patients. In this situation, the adre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::35b5734393dd6c2d5a840a7c48d9e62e
https://pubmed.ncbi.nlm.nih.gov/4035538
https://pubmed.ncbi.nlm.nih.gov/4035538
Publikováno v:
Circulatory shock. 20(2)
We determined how the following drugs affected survival of 350-gm Sprague-Dawley rats subjected to intra-abdominal sepsis according to the method of Wichterman et al (J Surg Res 29:189-201, 1980): gentamicin (4.5 mg/kg/day), clindamycin (30 mg/kg/day
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3b26c67a1e755f3114910eb8fd0c9c60
https://pubmed.ncbi.nlm.nih.gov/3779905
https://pubmed.ncbi.nlm.nih.gov/3779905
Publikováno v:
The Journal of trauma. 27(1)
We evaluated the hemodynamic response of 12% shed blood replacement with 7.5% sodium chloride after a nonlethal hemorrhage in chronically instrumented swine. Compared to no treatment or Ringer's lactate infusion, the hypertonic salt solution was foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6d323f73aeb2d485ee7545c05e87cb1e
https://pubmed.ncbi.nlm.nih.gov/3806709
https://pubmed.ncbi.nlm.nih.gov/3806709
Publikováno v:
Advances in Econometrics; 2024, Vol. 46, p265-308, 44p